BR0313806A - Vacinas para infecções nos sistemas respiratório e reprodutor em gado - Google Patents
Vacinas para infecções nos sistemas respiratório e reprodutor em gadoInfo
- Publication number
- BR0313806A BR0313806A BR0313806-2A BR0313806A BR0313806A BR 0313806 A BR0313806 A BR 0313806A BR 0313806 A BR0313806 A BR 0313806A BR 0313806 A BR0313806 A BR 0313806A
- Authority
- BR
- Brazil
- Prior art keywords
- leptospira
- cattle
- vaccines
- infections
- respiratory
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 241000283690 Bos taurus Species 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 230000000241 respiratory effect Effects 0.000 title abstract 2
- 210000002345 respiratory system Anatomy 0.000 title abstract 2
- 210000004994 reproductive system Anatomy 0.000 title 1
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 241000711895 Bovine orthopneumovirus Species 0.000 abstract 1
- 241000589874 Campylobacter fetus Species 0.000 abstract 1
- 241000589902 Leptospira Species 0.000 abstract 1
- 241000589927 Leptospira borgpetersenii Species 0.000 abstract 1
- 241001550390 Leptospira interrogans serovar Canicola Species 0.000 abstract 1
- 241001518163 Leptospira interrogans serovar Hardjo-bovis Species 0.000 abstract 1
- 241001518154 Leptospira kirschneri serovar Grippotyphosa Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 abstract 1
- 229940001442 combination vaccine Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 241001529453 unidentified herpesvirus Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/265—Infectious rhinotracheitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/28011—Hepeviridae
- C12N2770/28022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Pregnancy & Childbirth (AREA)
- Toxicology (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
"VACINAS PARA INFECçõES NOS SISTEMAS RESPIRATóRIO E REPRODUTOR EM GADO". A presente invenção refere-se a vacinas de combinação e métodos para tratar ou evitar doenças ou distúrbios em um animal, causados por Vírus da Diarreia Viral Bovina (BVDV) Tipos 1 e 2, Viruas da Herpes Bovina Tipo 1 (BHV-1) Vírus Sincitial Respiratório Bovino (BRSV), Vírus da Parainfluenza (PI~ 3~), Campylobacter fetus, Leptospira canicola, Leptospira grippotyphosa, Leptospira borgpetersenii hardjo-prajitno, Leptospira icterohaemmorrhagia, Leptospira hardjo-bovis e Leptospira pomona, por administração ao animal de uma quantidade eficaz de uma vacina combinada. A vacina de combinação pode ser uma célula alterada total ou parcial ou uma preparação viva modificada.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40596902P | 2002-08-26 | 2002-08-26 | |
| PCT/IB2003/003633 WO2004017990A1 (en) | 2002-08-26 | 2003-08-14 | Vaccine for respiratory and reproductive system infections in cattle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0313806A true BR0313806A (pt) | 2005-07-05 |
Family
ID=31946951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0313806-2A BR0313806A (pt) | 2002-08-26 | 2003-08-14 | Vacinas para infecções nos sistemas respiratório e reprodutor em gado |
Country Status (32)
| Country | Link |
|---|---|
| US (4) | US20040081666A1 (pt) |
| EP (2) | EP1536830A1 (pt) |
| JP (4) | JP2006501237A (pt) |
| KR (2) | KR20060116037A (pt) |
| CN (1) | CN1315534C (pt) |
| AP (1) | AP2005003238A0 (pt) |
| AR (1) | AR041047A1 (pt) |
| AT (1) | ATE533506T1 (pt) |
| AU (2) | AU2003263390B2 (pt) |
| BR (1) | BR0313806A (pt) |
| CA (1) | CA2496750C (pt) |
| EA (1) | EA011578B1 (pt) |
| GT (1) | GT200300180A (pt) |
| HK (1) | HK1078457A1 (pt) |
| HR (2) | HRP20050192B1 (pt) |
| IS (1) | IS7672A (pt) |
| MA (1) | MA27388A1 (pt) |
| ME (1) | ME00810B (pt) |
| MX (1) | MXPA05002255A (pt) |
| NO (1) | NO20050603L (pt) |
| NZ (2) | NZ538394A (pt) |
| OA (1) | OA12915A (pt) |
| PA (1) | PA8581101A1 (pt) |
| PE (1) | PE20040420A1 (pt) |
| PL (1) | PL216541B1 (pt) |
| RS (1) | RS20050177A (pt) |
| TN (1) | TNSN05059A1 (pt) |
| TW (1) | TWI272105B (pt) |
| UA (1) | UA94689C2 (pt) |
| UY (1) | UY27948A1 (pt) |
| WO (1) | WO2004017990A1 (pt) |
| ZA (1) | ZA200501171B (pt) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7179473B2 (en) | 1998-06-05 | 2007-02-20 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
| US7135561B2 (en) | 2001-09-06 | 2006-11-14 | Boehringer Ingelheim Vetmedica Gmbh | Infectious bovine viral diarrhea virus clone |
| OA12915A (en) * | 2002-08-26 | 2006-10-13 | Pfizer Prod Inc | Vaccine for respiratory and reproductive system infections in cattle. |
| US20050089533A1 (en) * | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
| US7563449B2 (en) * | 2003-04-21 | 2009-07-21 | Pfizer Inc, | Methods for reducing cattle reproductive diseases |
| US7361357B2 (en) * | 2003-07-29 | 2008-04-22 | Pfizer Inc. | Safe mutant viral vaccines |
| DK1701738T3 (en) | 2003-12-17 | 2015-03-30 | Wyeth Llc | Process for preparing storage-stable RSV compositions |
| KR20070008625A (ko) * | 2004-04-05 | 2007-01-17 | 화이자 프로덕츠 인코포레이티드 | 미세유체화된 수중유 유화액 및 백신 조성물 |
| US7572455B2 (en) * | 2004-05-19 | 2009-08-11 | Boehringer Ingelheim Vetmedica Gmbh | Vaccine comprising an attenuated pestivirus |
| US20090068223A1 (en) * | 2005-11-15 | 2009-03-12 | Boehringer Ingelheim Vetmedica, Inc. | Combination vaccine comprising an attenuated bovine viral diarrhea virus |
| KR101238486B1 (ko) | 2006-09-11 | 2013-03-04 | 화이자 프로덕츠 인크. | 열 처리된 박테린, 및 상기 열 처리된 박테린으로부터 제조된 에멀젼 백신 |
| WO2008036747A2 (en) * | 2006-09-21 | 2008-03-27 | Amarillo Biosciences, Inc. | Composition and method for immunomodulation |
| US7803527B2 (en) * | 2007-10-31 | 2010-09-28 | Novartis Ag | Inactivated bovine herpes virus-1 and methods |
| CA2710186C (en) * | 2007-12-21 | 2015-11-03 | Pfizer Inc. | Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins |
| UY31930A (es) * | 2008-06-25 | 2010-01-29 | Boheringer Ingelheim Pharma Kg | Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante |
| EP2337582A1 (en) | 2008-10-03 | 2011-06-29 | Novartis AG | Bovine herpes virus -1 compositions, vaccines and methods |
| US8846054B2 (en) * | 2009-01-09 | 2014-09-30 | Boehringer Ingelheim Vetmedica, Inc. | Method of treating pregnant cows and/or heifers |
| CA2836805C (en) * | 2011-06-10 | 2023-03-07 | Novartis Ag | Bovine vaccines and methods |
| RU2522780C2 (ru) * | 2012-07-27 | 2014-07-20 | Государственное научное учреждение Всероссийский научно-исследовательский институт ветеринарной санитарии, гигиены и экологии Российской академии сельскохозяйственных наук | Способ получения вакцины против инфекционного ринотрахеита крупного рогатого скота |
| US9314519B2 (en) | 2012-08-21 | 2016-04-19 | Intervet Inc. | Liquid stable virus vaccines |
| US20140147475A1 (en) | 2012-11-29 | 2014-05-29 | Antonius Arnoldus Christiaan Jacobs | Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida |
| US9480739B2 (en) * | 2013-03-15 | 2016-11-01 | Intervet Inc. | Bovine virus vaccines that are liquid stable |
| US9393298B2 (en) | 2013-03-15 | 2016-07-19 | Intervet Inc. | Liquid stable bovine virus vaccines |
| MX357432B (es) | 2013-03-18 | 2018-07-09 | Intervet Int Bv | Vacuna para proteger a un rumiante contra la neumonia causada por mannheimia haemolytica. |
| AR097762A1 (es) | 2013-09-27 | 2016-04-13 | Intervet Int Bv | Formulaciones secas de vacunas que son estables a temperatura ambiente |
| AR099470A1 (es) | 2014-02-17 | 2016-07-27 | Intervet Int Bv | Vacunas de virus de aves de corral líquidas |
| TWI670085B (zh) | 2014-02-19 | 2019-09-01 | 荷蘭商英特威國際公司 | 液體穩定之豬病毒疫苗 |
| EP3402878A1 (en) | 2016-01-11 | 2018-11-21 | Zoetis Services LLC | Novel cross protective vaccine compositions for porcine epidemic diarrhea virus |
| BR112018069371A2 (pt) | 2016-03-21 | 2019-01-22 | South Dakota Board Of Regents | construção de ácido nucleico, vetor, vacina ou composição imunogênica, método de entrega de uma vacina, método de produção de uma construção de ácido nucleico e método para conferir imunidade contra um antígeno |
| PT3522871T (pt) | 2016-10-05 | 2022-01-05 | Zoetis Services Llc | Métodos de liofilização que fornecem protozoários estavelmente desidratados para utilização como vacinas vivas potentes |
| RU2643335C1 (ru) * | 2016-11-14 | 2018-01-31 | Федеральное государственное бюджетное образовательное учреждение высшего образования Санкт-Петербургская государственная академия ветеринарной медицины (ФГБОУ ВПО СПбГ АВМ) | Инактивированная бивалентная гидроокись алюминиевая вакцина против кампилобактериоза собак |
| GB201703529D0 (en) | 2017-03-06 | 2017-04-19 | Cambridge Entpr Ltd | Vaccine composition |
| CN110317749B (zh) * | 2019-06-19 | 2021-01-22 | 山东省农业科学院奶牛研究中心 | 一株牛支原体强毒株及其应用 |
| RU2764220C1 (ru) * | 2020-12-02 | 2022-01-14 | Федеральное государственное бюджетное научное учреждение "Краснодарский научный центр по зоотехнии и ветеринарии" ФГБНУ КНЦЗВ | Способ предупреждения риска заболевания парагриппом-3 у телят |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3634587A (en) * | 1969-11-06 | 1972-01-11 | Ralston Purina Co | Method of immunizing cattle against bovine respiratory disease syndrome |
| BE759425A (fr) * | 1969-11-28 | 1971-05-25 | Mebus Charles A | Vaccins contre la diarrhee du veau, leur preparation et emploi |
| US5593873A (en) | 1986-01-27 | 1997-01-14 | Syntro Corporation | Recombinant infectious bovine rhinotracheitis virus |
| US5084269A (en) | 1986-11-06 | 1992-01-28 | Kullenberg Fred W | Adjuvant for dose treatment with antigens |
| DE3768232D1 (de) * | 1986-12-19 | 1991-04-04 | Duphar Int Res | Dimethyldioctadecylammoniumbromid enthaltende stabilisierte adjuvanssuspension. |
| US6291228B1 (en) * | 1988-08-03 | 2001-09-18 | Vericore Limited | Vaccine |
| GB8818415D0 (en) * | 1988-08-03 | 1988-09-07 | Animal Health Inst | Vaccine |
| MX9301736A (es) | 1992-03-30 | 1994-01-31 | Smithkline Beecham Corp | Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1. |
| US5951988A (en) * | 1993-03-30 | 1999-09-14 | University Of Saskatchewan | Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods |
| AU688819B2 (en) | 1993-11-05 | 1998-03-19 | Bayer Aktiengesellschaft | Viral vector with bovine viral diarrhea virus (BVDV) antigens |
| SI0759780T1 (en) * | 1994-05-10 | 2000-12-31 | American Home Products Corporation | Improved modified live brsv vaccine |
| US5709865A (en) | 1994-11-10 | 1998-01-20 | Biostar Inc. | Immunogenic composition against Bovine Viral Diarrhea Virus II glycoprotein 53 (BVDV-II gp53) |
| US6001613A (en) | 1996-05-24 | 1999-12-14 | Board Of Regents Of University Of Nebraska | Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid |
| US6060457A (en) | 1996-06-20 | 2000-05-09 | Universite De Montreal | DNA plasmid vaccine for immunization of animals against BVDV |
| BR9803232A (pt) * | 1997-08-26 | 2000-01-11 | Pfizer Prod Inc | Vaicna de neospora. |
| EP1279401B1 (en) | 1997-09-05 | 2008-01-09 | GlaxoSmithKline Biologicals S.A. | Oil in water emulsions containing saponins |
| UA78180C2 (uk) * | 1997-10-03 | 2007-03-15 | Меріаль | Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти |
| EP0924295A3 (en) | 1997-12-04 | 2001-05-16 | Pfizer Products Inc. | DNA encoding neospora dihydrofolate reductase-thymidylate synthase |
| WO1999055366A1 (en) | 1998-04-24 | 1999-11-04 | Washington University | Chimeras of hepatitis c virus and bovine viral diarrhea virus |
| AU769539B2 (en) * | 1999-01-29 | 2004-01-29 | Zoetis Services Llc | Adjuvants for use in vaccines |
| OA12915A (en) | 2002-08-26 | 2006-10-13 | Pfizer Prod Inc | Vaccine for respiratory and reproductive system infections in cattle. |
| JP5179521B2 (ja) | 2007-03-05 | 2013-04-10 | カディラ・ヘルスケア・リミテッド | ペグ‐インターフェロンアルファ接合体および凍結保護剤としてラフィノースを含む組成物 |
-
2003
- 2003-08-14 OA OA1200500058A patent/OA12915A/en unknown
- 2003-08-14 NZ NZ538394A patent/NZ538394A/en not_active IP Right Cessation
- 2003-08-14 UA UAA200501771A patent/UA94689C2/ru unknown
- 2003-08-14 EA EA200500275A patent/EA011578B1/ru not_active IP Right Cessation
- 2003-08-14 WO PCT/IB2003/003633 patent/WO2004017990A1/en active Application Filing
- 2003-08-14 BR BR0313806-2A patent/BR0313806A/pt not_active Application Discontinuation
- 2003-08-14 MX MXPA05002255A patent/MXPA05002255A/es active IP Right Grant
- 2003-08-14 CN CNB038203162A patent/CN1315534C/zh not_active Expired - Lifetime
- 2003-08-14 KR KR1020067022893A patent/KR20060116037A/ko active Search and Examination
- 2003-08-14 RS YUP-2005/0177A patent/RS20050177A/sr unknown
- 2003-08-14 JP JP2004530459A patent/JP2006501237A/ja active Pending
- 2003-08-14 AP AP2005003238A patent/AP2005003238A0/xx unknown
- 2003-08-14 PL PL375548A patent/PL216541B1/pl unknown
- 2003-08-14 EP EP03792580A patent/EP1536830A1/en not_active Ceased
- 2003-08-14 KR KR1020057003230A patent/KR20050062542A/ko active Search and Examination
- 2003-08-14 CA CA2496750A patent/CA2496750C/en not_active Expired - Lifetime
- 2003-08-14 AT AT06122758T patent/ATE533506T1/de active
- 2003-08-14 EP EP06122758A patent/EP1743652B1/en not_active Expired - Lifetime
- 2003-08-14 ME MEP-2009-213A patent/ME00810B/me unknown
- 2003-08-14 NZ NZ565206A patent/NZ565206A/en not_active IP Right Cessation
- 2003-08-14 AU AU2003263390A patent/AU2003263390B2/en not_active Expired
- 2003-08-20 TW TW092122872A patent/TWI272105B/zh not_active IP Right Cessation
- 2003-08-22 UY UY27948A patent/UY27948A1/es not_active Application Discontinuation
- 2003-08-22 PE PE2003000857A patent/PE20040420A1/es not_active Application Discontinuation
- 2003-08-25 GT GT200300180A patent/GT200300180A/es unknown
- 2003-08-25 PA PA20038581101A patent/PA8581101A1/es unknown
- 2003-08-25 AR ARP030103054A patent/AR041047A1/es unknown
- 2003-08-26 US US10/647,919 patent/US20040081666A1/en not_active Abandoned
-
2005
- 2005-01-27 IS IS7672A patent/IS7672A/is unknown
- 2005-02-03 NO NO20050603A patent/NO20050603L/no not_active Application Discontinuation
- 2005-02-09 ZA ZA200501171A patent/ZA200501171B/en unknown
- 2005-02-25 MA MA28121A patent/MA27388A1/fr unknown
- 2005-02-25 TN TNP2005000059A patent/TNSN05059A1/fr unknown
- 2005-02-28 HR HRP20050192AA patent/HRP20050192B1/hr not_active IP Right Cessation
- 2005-11-18 HK HK05110344A patent/HK1078457A1/xx not_active IP Right Cessation
-
2007
- 2007-08-30 US US11/897,421 patent/US20070298053A1/en not_active Abandoned
-
2008
- 2008-12-16 AU AU2008258154A patent/AU2008258154B2/en not_active Expired
-
2009
- 2009-05-14 HR HR20090271A patent/HRP20090271A2/xx not_active Application Discontinuation
- 2009-05-15 JP JP2009118662A patent/JP2009215309A/ja not_active Withdrawn
-
2010
- 2010-06-22 US US12/820,566 patent/US9662384B2/en active Active
-
2011
- 2011-12-16 JP JP2011275303A patent/JP5785073B2/ja not_active Expired - Lifetime
-
2012
- 2012-12-28 US US13/729,206 patent/US20130129779A1/en not_active Abandoned
-
2015
- 2015-06-03 JP JP2015113008A patent/JP2015172069A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0313806A (pt) | Vacinas para infecções nos sistemas respiratório e reprodutor em gado | |
| BRPI0409640A (pt) | método de prevenção de doenças de reprodução de gado | |
| PL330879A1 (en) | Recombine live vaccine based on canine herpes virus, in particular against carre disease, rabies or parainfluenza virus of type 2 | |
| WO2003004051A3 (en) | Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle | |
| BG108496A (en) | Mycoplasma bovis vaccine and methods of reducing pneumonia in animals | |
| Valarcher et al. | Viral respiratory infections in cattle | |
| RU2006133328A (ru) | Способ вакцинации против инфекции семенников bvdv | |
| BR0016419A (pt) | Método para o aumento das respostas de imunização com relação a vacina do vìrus do herpes simplex | |
| ES2176330T3 (es) | Compuestos y composiciones para administracion por inhalacion oral o insuflacion. | |
| PT784486E (pt) | Inerleucina-12 como um adjuvante para vacinas contra paramyxoviridae | |
| BR0108735A (pt) | Proteção in ovo contra bronquite infecciosa | |
| DOP2003000699A (es) | Vacunas para enfermedades reproductoras del ganado | |
| BR0007966A (pt) | Composições e métodos para o tratamento e a prevenção de infecção bacteriana patogênica com base na função essencial da metilação do dna na virulência bacteriana | |
| CO5690616A2 (es) | Vacunas para enfermedades reproductoras del ganado | |
| Wittmann | Aujeszky’s disease (Pseudorabies) in ruminants | |
| Lobetti | Viral diseases of the dog. | |
| Tekdek et al. | An outbreak of canine tracheobronchitis (kennel cough) in Zaria | |
| Sharon | Effects of on-arrival, delayed vaccination and supplemental lysine on performance, antibody titer, temperature and metabolic profiles in response to modified-live viral respiratory vaccination | |
| TH72040A (th) | วิธีสำหรับการป้องกันโรคระบบสืบพันธุ์ของวัวควาย | |
| Rao | Prevalence, treatment and control of haemorrhagic septicaemia in sheep. | |
| O’Connell et al. | The development and testing of a vaccine for the prevention of infectious bovine keratoconjuctivitis | |
| Wizigmann | Vaccination against bovine enzootic pneumonia | |
| Makoschey et al. | Combined application of an inactivated IBR marker vaccine and an inactivated BVD vaccine. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: PAH USA 15 LLC (US) |
|
| B25D | Requested change of name of applicant approved |
Owner name: ZOETIS P LLC (US) |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O,13, 25 DA LPI |
|
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: ZOETIS SERVICES LLC (US) |
|
| B25G | Requested change of headquarter approved |
Owner name: ZOETIS SERVICES LLC (US) |